Skip to main content
. 2018 Mar 8;8(8):2161–2170. doi: 10.7150/thno.23335

Figure 1.

Figure 1

Intraoperative gamma probe measurements (T:N ratios). Each dot represents one patient and the horizontal line represents the mean per dose level. The highest T:N ratios were observed after administration of 10 mg 111In-DOTA-girentuximab-IRDye800CW, but differences between the dose levels were not statistically significant. The T:N ratio in the CAIX-negative tumors was significantly lower than in the CAIX-positive tumors (p<0.05).

HHS Vulnerability Disclosure